Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 16, 2007 - Issue 7
Submit an article Journal homepage
50
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Does a selective muscarinic receptor (M3) antagonist enhance the efficacy through oral delivery in chronic obstructive pulmonary disease patients?

LU S, PAREKH DD, KUZNETSOVA O et al.: An oral selective M3 cholinergic receptor antagonist in COPD. Eur. Respir. J. (2006) 28:772-780.

Krishna S Naruganahalli Ranbaxy Research Laboratories, Department of Pharmacology, New Drug Discovery Research, Plot 20, Sector 18, Gurgaon-122 015, Haryana, India. [email protected]
Pages 1127-1130 | Published online: 26 Jun 2007

Bibliography

  • LOPEZ AD, MURRAY CC: The global burden of disease 1990-2020. Nat Med. (1998) 4:1241-1243.
  • BARNES PJ: Mediators of chronic obstructive pulmonary disease. Pharmacol. Rev. (2004) 56:515-548.
  • HOGG JC, UTOKAPARCH S, YAMADA Y et al.: The nature of small airway obstruction in chronic pulmonary obstructive disease. New Engl. J. Med. (2004) 350:2645-2653.
  • NADEL J, BARNES PJ: Autonomic regulation of the airways. Ann. Rev. Med. (1984) 35:451-467.
  • MAK JC, BARNES PJ: Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am. Rev. Respir. Dis. (1990) 141:1559-1568.
  • SCALVINI S, PORTA R, ZANELLI E: Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease. Eur. Respir. J. (1999) 13:119-124.
  • BARNES PJ: The role of anticholinergics in chronic obstructive pulmonary disease. Am. J. Med. (2004) 20:24S-32S.
  • CASABURI R, MAHLER DA, JONES PW: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. (2002) 19:217-224.
  • LU S, PAREKH DD, KUZNETSOVA O et al.: An oral selective M3 cholinergic receptor antagonist in COPD. Eur. Respir. J. (2006) 28:772-780.
  • RACKE K, MATTHIESEN S: The airway cholinergic system: physiology and pharmacology. Pulm. Pharmacol. Ther. (2004) 17:181-198.
  • PROFITA M, GIORGI RD, SALA A: Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy (2005) 60:1361-1369.
  • SALPETER SR, BUCKLEY NS, SALPETER EE: Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J. Gen. Intern. Med. (2006) 21:1011-1019.
  • SANDERS M: Inhalation therapy: an historical review. Prim. Care Respir. J. (2007) (In Press).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.